SE393376B - Forfarande for framstellning av pyrimidinonderivat - Google Patents
Forfarande for framstellning av pyrimidinonderivatInfo
- Publication number
- SE393376B SE393376B SE7212358A SE1235872A SE393376B SE 393376 B SE393376 B SE 393376B SE 7212358 A SE7212358 A SE 7212358A SE 1235872 A SE1235872 A SE 1235872A SE 393376 B SE393376 B SE 393376B
- Authority
- SE
- Sweden
- Prior art keywords
- pyrimidinon
- derivatives
- preparing
- procedure
- pyrimidinon derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19400671A | 1971-10-29 | 1971-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE393376B true SE393376B (sv) | 1977-05-09 |
Family
ID=22715935
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7212358A SE393376B (sv) | 1971-10-29 | 1972-09-25 | Forfarande for framstellning av pyrimidinonderivat |
SE7505279A SE397090B (sv) | 1971-10-29 | 1975-05-06 | Forfarande for framstellning av hydroxipyrimidiner |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7505279A SE397090B (sv) | 1971-10-29 | 1975-05-06 | Forfarande for framstellning av hydroxipyrimidiner |
Country Status (25)
Country | Link |
---|---|
JP (2) | JPS5337870B2 (de) |
AR (2) | AR198798A1 (de) |
AT (2) | AT321308B (de) |
AU (1) | AU467600B2 (de) |
BE (1) | BE790125A (de) |
CA (1) | CA980778A (de) |
CH (2) | CH555832A (de) |
DE (3) | DE2248741C3 (de) |
DK (1) | DK131465B (de) |
EG (1) | EG11013A (de) |
ES (2) | ES407730A1 (de) |
FI (1) | FI55503C (de) |
FR (1) | FR2157865B1 (de) |
GB (2) | GB1377308A (de) |
IE (1) | IE37043B1 (de) |
IL (2) | IL40458A (de) |
LU (1) | LU66304A1 (de) |
NL (1) | NL166470C (de) |
NO (1) | NO136574C (de) |
PH (2) | PH10129A (de) |
PL (2) | PL84634B1 (de) |
SE (2) | SE393376B (de) |
SU (2) | SU498908A3 (de) |
YU (2) | YU35125B (de) |
ZA (1) | ZA727362B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55151912U (de) * | 1979-04-17 | 1980-11-01 | ||
JPS5752409Y2 (de) * | 1979-11-05 | 1982-11-15 | ||
DE3222914A1 (de) * | 1982-06-18 | 1983-12-22 | Beiersdorf Ag, 2000 Hamburg | Substituierte 5-phenylthio-6-amino-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |
JPH0655686B2 (ja) * | 1988-08-30 | 1994-07-27 | 宇部興産株式会社 | p−ブロモフェノキシアセトアルデヒドジアルキルアセタール類の製造方法 |
ATE533488T1 (de) | 2005-08-22 | 2011-12-15 | Melior Pharmaceuticals I Inc | Verfahren und formulierungen zur modulierung von lyn-kinaseaktivität und behandlung assoziierter erkrankungen |
US8552184B2 (en) | 2008-07-03 | 2013-10-08 | Melior Pharmaceuticals I, Inc. | Compounds and methods for treating disorders related to glucose metabolism |
US20130158055A1 (en) | 2010-05-28 | 2013-06-20 | Andrew G. Reaume | Prevention Of Pancreatic Beta Cell Degeneration |
EP3609500B1 (de) | 2017-04-10 | 2024-11-13 | Melior Pharmaceuticals I, Inc. | Behandlung von adipozyten |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2913462A (en) * | 1959-11-17 | Eahl h | ||
GB951432A (en) * | 1959-03-17 | 1964-03-04 | Wellcome Found | Pyrimidine derivatives and the manufacture thereof |
-
0
- BE BE790125D patent/BE790125A/xx not_active IP Right Cessation
-
1972
- 1972-02-18 GB GB774872A patent/GB1377308A/en not_active Expired
- 1972-02-18 GB GB5005373A patent/GB1377720A/en not_active Expired
- 1972-09-25 SE SE7212358A patent/SE393376B/xx unknown
- 1972-09-28 IL IL40458A patent/IL40458A/en unknown
- 1972-09-28 AU AU47228/72A patent/AU467600B2/en not_active Expired
- 1972-10-02 PH PH13959A patent/PH10129A/en unknown
- 1972-10-05 DE DE2248741A patent/DE2248741C3/de not_active Expired
- 1972-10-05 DE DE2264374A patent/DE2264374C3/de not_active Expired
- 1972-10-05 DE DE2264657A patent/DE2264657C2/de not_active Expired
- 1972-10-06 AT AT858972A patent/AT321308B/de not_active IP Right Cessation
- 1972-10-06 AT AT00933/74A patent/AT320656B/de not_active IP Right Cessation
- 1972-10-12 FI FI2825/72A patent/FI55503C/fi active
- 1972-10-12 YU YU2551/72A patent/YU35125B/xx unknown
- 1972-10-13 SU SU1839308A patent/SU498908A3/ru active
- 1972-10-13 NO NO3686/72A patent/NO136574C/no unknown
- 1972-10-16 NL NL7213959.A patent/NL166470C/xx not_active IP Right Cessation
- 1972-10-16 ZA ZA727362A patent/ZA727362B/xx unknown
- 1972-10-16 CA CA153,956A patent/CA980778A/en not_active Expired
- 1972-10-16 JP JP10279972A patent/JPS5337870B2/ja not_active Expired
- 1972-10-16 DK DK510072AA patent/DK131465B/da not_active IP Right Cessation
- 1972-10-16 IE IE1398/72A patent/IE37043B1/xx unknown
- 1972-10-16 FR FR7236560A patent/FR2157865B1/fr not_active Expired
- 1972-10-16 CH CH1507872A patent/CH555832A/fr not_active IP Right Cessation
- 1972-10-16 PL PL1972158297A patent/PL84634B1/pl unknown
- 1972-10-16 CH CH165674A patent/CH549579A/fr not_active IP Right Cessation
- 1972-10-16 PL PL1972174103A patent/PL89852B1/pl unknown
- 1972-10-16 LU LU66304A patent/LU66304A1/xx unknown
- 1972-10-18 ES ES407730A patent/ES407730A1/es not_active Expired
- 1972-10-19 EG EG431/72A patent/EG11013A/xx active
- 1972-10-23 AR AR244763A patent/AR198798A1/es active
-
1973
- 1973-07-12 AR AR249053A patent/AR196263A1/es active
-
1974
- 1974-03-26 SU SU2008490A patent/SU505362A3/ru active
-
1975
- 1975-04-15 ES ES436624A patent/ES436624A1/es not_active Expired
- 1975-05-06 SE SE7505279A patent/SE397090B/xx unknown
- 1975-11-21 PH PH17784A patent/PH11594A/en unknown
-
1976
- 1976-01-05 IL IL48790A patent/IL48790A/en unknown
-
1978
- 1978-02-08 JP JP1336078A patent/JPS53116386A/ja active Granted
-
1979
- 1979-04-25 YU YU991/79A patent/YU36295B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE422325B (sv) | Forfarande for framstellning av vissa angivna 1,2,4-triazolderivat | |
SE432102B (sv) | Forfarande for framstellning av estrar av penicilliner | |
SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
SE400771B (sv) | Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner | |
SE413246B (sv) | Forfarande for framstellning av kolesteroloxidas | |
SE383358B (sv) | Forfarande for framstellning av pullulan | |
SE399268B (sv) | Forfarande for framstellning av nya purinnukleosidderivat | |
NO145918C (no) | Fremgangsmaate for fremstilling av 7-acylamido-3-cefem-4-karboksylsyrer | |
SE419339B (sv) | Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner | |
SE397530B (sv) | Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat | |
NO139124C (no) | Fremgangsmaate for fremstilling av estere | |
SE382809B (sv) | Forfarande for framstellning av fenoxiettiksyraderivat | |
AR200387A1 (es) | Procedimiento para preparar derivados de trifluorometilfenilpiperazina | |
SE423092B (sv) | Forfarande for framstellning av vissa 13-tiaprostaglandiner | |
SE417711B (sv) | Forfarande for framstellning av 5-iminometyl-2-nitroimidazolderivat | |
SE393376B (sv) | Forfarande for framstellning av pyrimidinonderivat | |
SE395455B (sv) | Forfarande for framstellning av 3-(fenyl-piperazinyl) etylindoliner | |
SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
SE387344B (sv) | Forfarande for framstellning av pyrazin-4-oxidderivat | |
SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
SE409858B (sv) | Forfarande for framstallning av vissa angivna aminoalkylfenylacetonitrilderivat | |
SE380528B (sv) | Forfarande for framstellning av 2-klor-7-hydroxi-11-piperazinyldibensoxazepmderivat | |
SE373572B (sv) | Forfarande for framstellning av pyroglutamyl-histidyl-prolinamid | |
SE402454B (sv) | Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen | |
IT966747B (it) | Procedimento per preparare dinitroantrachinoni |